Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2025-12-24 @ 1:36 PM
NCT ID: NCT03693495
Eligibility Criteria: Inclusion Criteria: * Male and female participants aged 3 years of age or older * Must currently be presenting with symptoms characteristic of pharyngitis, possibly Group A Strep, including: * Acute onset of sore throat; * Fever ≥ 37.8° C (100° F) at presentation or history or parent/guardian-reported history of fever ≥ 37.8° C or feeling feverish within 24 hours of presentation and; * At least one of the following: * Red and swollen/inflamed tonsils (or fossae); * Pharyngeal or tonsillar exudate; o Cervical lymphadenopathy * ≤ 14 days from onset of signs and symptoms of pharyngitis * Parent/legal guardian of Participants \< 18 years of age capable and willing to give informed consent * Participants ≥18 years of age capable and willing to give informed consent Exclusion Criteria: * Participants \< 3 years of age * Participants undergoing treatment with antibiotics, or those who have undergone treatment with antibiotics for current episode of pharyngitis * Currently enrolled in another clinical trial or used any investigational device within 30 days preceding informed consent * Participants 18 years of age or older unable to understand English and consent to participation * Parent/legal guardian of Participants \< 18 years of age unable to understand English and consent to participation of child * Prior enrollment in this clinical validation study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 3 Years
Study: NCT03693495
Study Brief:
Protocol Section: NCT03693495